Related Experiment Video
Updated: Jan 13, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Long-Term Outcomes in Moderate and Severe Aortic Stenosis According to Extent of Cardiac Damage
Domenico Angellotti1, Christoph Ryffel2, Lisa Schmid3
1Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Advanced Biomedical Science, University of Naples Federico II, Naples, Italy.
Insights
Cardiac damage extent significantly impacts 10-year mortality in aortic stenosis (AS) patients. Aortic valve replacement (AVR) improved survival, especially in severe AS with advanced cardiac damage (CD).
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Prognostics
Background:
- Cardiac damage (CD) is a critical factor influencing prognosis in patients with aortic stenosis (AS).
- Understanding the long-term implications of CD is essential for managing AS patients effectively.
Purpose of the Study:
- To investigate the impact of cardiac damage extent on long-term survival in patients with moderate and severe aortic stenosis.
- To evaluate the effectiveness of aortic valve replacement (AVR) in relation to cardiac damage and AS severity.
Main Methods:
- Pooled analysis of two single-center registries including patients with moderate or severe AS.
- Classification of patients based on the presence of early (stages 0-1) or advanced (stages 2-4) cardiac damage.
- Statistical analysis of 10-year mortality risk and the association of AVR with outcomes, adjusted for AS severity and CD stage.
Main Results:
- A gradual increase in 10-year mortality risk was observed with increasing AS severity and CD extent.
- Advanced CD was present in 79.4% of the 626 included patients, with a median follow-up of 7.4 years.
- Aortic valve replacement (AVR) was associated with significantly lower mortality in patients with advanced CD, irrespective of AS severity, and in severe AS with early CD.
Conclusions:
- The extent of cardiac damage is a key determinant of 10-year mortality in patients with moderate to severe AS.
- Aortic valve replacement (AVR) demonstrates a survival benefit, particularly in patients with moderate AS and advanced cardiac damage.
Background:
Cardiac damage (CD) significantly affects the prognosis of patients with aortic stenosis (AS).
Objectives:
The aim of this study was to investigate the impact of CD on long-term survival in patients with moderate and severe AS.
Methods:
In a pooled analysis of 2 single-center registries, patients with moderate or severe AS were included according to the presence of early (stages 0 and 1) or advanced (stages 2-4) CD.
Results:
Among 1,096 patients with AS included between 2009 and 2023, 626 patients (mean age 78.9 ± 8.0 years, 33.1% women) had moderate (n = 343) or severe AS (n = 283). Advanced CD was present in 497 patients (79.4%), and the median follow-up duration was 7.4 years (Q1-Q3: 4.2-10.6 years). There was a gradual increase in the risk for 10-year mortality from moderate to severe AS and from early CD (moderate AS: reference; severe AS: adjusted HR [aHR]: 1.42; 95% CI: 0.75-2.72) to advanced CD (moderate AS: aHR: 1.91; 95% CI: 1.22-2.97; severe AS: aHR: 2.77; 95% CI: 1.73-4.45). At a median 347 days, 344 patients (54.9%) had undergone aortic valve replacement (AVR). In patients with advanced CD, AVR was associated with lower mortality compared with conservative management, irrespective of AS severity (moderate AS: aHR: 0.43; 95% CI: 0.28-0.66; severe AS: aHR: 0.27; 95% CI: 0.18-0.39). In patients with early CD, AVR was associated with lower mortality in patients with severe AS (aHR: 0.29; 95% CI: 0.10-0.86), but not in those with moderate AS (aHR: 0.61; 95% CI: 0.25-1.44).
Conclusions:
Ten-year mortality in patients with moderate and severe AS is importantly determined by CD extent. AVR was associated with lower mortality in patients with moderate AS and advanced CD.
More Related Videos
14:14Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
06:51Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
Related Concept Videos
Mitral Stenosis I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation IV: Nursing Management